Loss-of-function variants in EPHX3 cause nonsyndromic epidermal differentiation disorders

Clicks: 1
ID: 314872
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #161 of 302 articles by views in the british journal of dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 302 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
BACKGROUND: Epidermal differentiation disorders (EDD) are inherited keratinization disorders with remarkable clinical and genetic heterogeneity. Defects in epidermal lipid metabolism and corneocyte lipid envelope assembly account for a subset of EDD. Epoxide hydrolase 3 (EH3), encoded by EPHX3, mediates hydrolysis of linoleate-derived lipid epoxides during barrier formation. While Ephx3-deficient mice exhibit impaired skin barrier function, no human disorders caused by EPHX3 variants have been reported to date. OBJECTIVES: To determine the genetic basis of a new subtype of nonsyndromic EDD (nEDD) presenting from early infancy with generalized erythematous patches and plaques, xerosis, and skin peeling. We also assessed the impact of EH3 deficiency on epidermal lipid processing. METHODS: Whole-exome sequencing was performed in three unrelated families with nEDD to investigate the underlying genetic causes. The skin biopsy from one representative patient was analysed using immunofluorescence staining and lipid staining. Liquid chromatography-mass spectrometry was employed to quantify EH3 activity. Patient-derived primary keratinocytes were used to generate three-dimensional (3D) skin equivalents to assess epidermal differentiation. RESULTS: Three affected individuals from Chinese, Pakistani Irish, and Russian families with nEDD were enrolled. Biallelic EPHX3 variants (c.74G>A, p.Trp25*; c.289G>T, p.Gly97*; c.524G>A, p.Gly175Asp; c.908G>A, p.Trp303* and c.1033delC, p.Gln345Argfs*51) were identified in the patients. Total trihydroxyoctadecenoic acid was reduced in tape-stripping stratum corneum extracts from affected individuals, suggesting reduced EH3-dependent epoxide hydrolysis in vivo. Consistently, carriers of EPHX3 variants showed markedly reduced epoxide-hydrolase activity in vitro. Nile red staining on the patient's skin lesion revealed reduced and redistributed lipids, suggesting a disturbed stratum corneum lipid barrier. Patient's keratinocyte-constructed 3D skin equivalent showed disrupted stratum corneum, more extensive keratin 1, increased loricrin and Ki-67, and reduced claudin-1 staining. CONCLUSIONS: We report biallelic loss-of-function EPHX3 variants causing a new subtype of nEDD. Our study also supports an important role of EH3-dependent epoxide hydrolysis in epidermal barrier lipid processing.
Reference Key
openalex_W7162335439 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kunlun Lv, Karina Forde, Amanda Moon, Zeqiao Zhang, Lewis Pang, Tomoki Nomakuchi, Sisi Zhao, Jill R. Murrell, Kathleen H. Wood, Alan D. Irvine, Christopher Gray, Zhimiao Lin, H Wang
Journal the british journal of dermatology
Year 2026
DOI
10.1093/bjd/ljag213
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.